Navigation Links
Product Strategies for Non-Oral Hematology Drugs

DUBLIN, March 22, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Product Strategies for Non-Oral Hematology Drugs" report to their offering.

The administration of non-oral drugs for the treatment of blood disorders has evolved over the past ten years to include heparin analogs and recombinant proteins designed to treat chronic conditions that are life threatening and often debilitating illnesses. As the availability of drugs based on new APIs or molecular entities has grown, the product strategies in the marketplace have increased in specificity and sophistication.

The chronic nature of many blood diseases and the growing trend toward patient self-administration for non-oral medications is requiring drug developers and product managers to refine their product strategy at the highest level, with formulation and device selection decisions being made prior to the clinical trial phase of development.

Key Topics Covered:

Executive Summary

Therapeutic Hematology Market Dynamics
- Evolution in Drug Therapies
- Growth of Self-Administration
- Key Markets for Hematology Drug Therapeutics
- Anemia
- Deep Vein Thrombosis
- Heart Valve Prosthesis
- Neutropenia
- Pulmonary Embolism
- Competitive Landscape
- Opportunities and Risks

Non-Oral Hematology Drug Formulation and Packaging Factors
- Extended Release Formulations
- Packaging - Vial vs Prefilled Device
- Vial Strategies
- Prefilled Device Strategies
- Prefilled Syringes
- Autoinjectors
- Pen Injectors

Non-Oral Hematology Drug Administration Factors
- Dosing
- Dose Frequency
- Route of Administr

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA
3. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
4. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
5. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
6. China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)
7. National Stakeholders Meet To Consider Improvements In Antimicrobial Use In Food Animal Production
8. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
9. China Biologic Products Reports Higher Results for the First Quarter 2012
10. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
11. Allied Healthcare Products Reports Loss on Sales Decline
Post Your Comments:
(Date:10/8/2015)... 8, 2015 " Biomedical Refrigerators ... Trends and Forecast 2014 - 2022 " , the ... billion in 2013 and is anticipated to expand at a ... 4.00 billion in 2022. --> " Biomedical ... Growth, Trends and Forecast 2014 - 2022 " , ...
(Date:10/8/2015)... DUBLIN , Oct. 08 2015 /PRNewswire/ ... announced the addition of the "Natural ... Life Sciences Industry by Type (Rule-Based, Statistical, ... Europe, Asia-Pacific, Middle East and Africa, Latin ... report to their offering. --> ...
(Date:10/8/2015)... -- Celtaxsys, a clinical stage drug development company focused on ... announced today the commencement of the US arm of ... compound, acebilustat, in patients with cystic fibrosis (CF). The ... the United States and European ... early 2016. This landmark clinical trial testing once-daily oral ...
Breaking Medicine Technology:
... July 20, 2011 Savient Pharmaceuticals, Inc. (NASDAQ: ... results for the second quarter 2011 prior to the open ... John H. Johnson, Chief Executive Officer and President, and ... host an investment community conference call beginning at 9:00 a.m. ...
... LOUISVILLE, Ky., July 20, 2011 BellaNovus Development ... today announced its launch of the Ouchless™ Needle ... an innovative alternative to numbing creams and ice ... cosmetic injectables, such as Botox® and dermal fillers. ...
Cached Medicine Technology:
(Date:10/9/2015)... , ... October 09, 2015 , ... ... upcoming episode of Innovations with Ed Begley Jr., airing 1st QT 2016 via ... will educate audiences on MMJ Phytotech Limited (MMJ) – a global leader in ...
(Date:10/9/2015)... Bethesda, Maryland (PRWEB) , ... October 09, 2015 ... ... care and assisted living placement counseling, recently opened its newest office in Maryland ... the senior care industry with a background as a project management technology consultant ...
(Date:10/9/2015)... ... October 09, 2015 , ... The Kitchenistas of National ... diabetes, obesity, and other health conditions related to food, has been selected for viewing ... at the Global Health Film Festival on October 30-31 in London, England. , The ...
(Date:10/9/2015)... Abilene, Texas (PRWEB) , ... October 09, 2015 , ... ... new article this week that takes the subject of health care back to the ... too many sicknesses that are able to be prevented if only biblical laws were ...
(Date:10/8/2015)... ... October 09, 2015 , ... The Guthrie Sports Medicine/Twin Tiers ... support post-concussion group was started by Steven Hicks, a Licensed Athletic Trainer, with ... was started in November 2010 to help support student athletes, their ...
Breaking Medicine News(10 mins):
... may be related to trend toward less sleep, ... to the many reasons why people should get adequate sleep, ... insulin resistance, a component of type 2 diabetes. , The ... after a night of normal sleep (about eight hours) and ...
... In ... Trade to the table with Tampa Bay’s greenest coffee roasters. , ... Tampa, Fla. (PRWEB) May 6, 2010 -- Java Planet, ... and commitment to Fair Trade by gaining the certifications needed to be able to use ...
... anatomical alterations in children with genetic disorder , THURSDAY, May ... with fragile X syndrome differs from that in boys without ... X syndrome, which is triggered by a mutation in a ... inherited intellectual disability and autism. Though the syndrome affects ...
... is safe, improves blood sugar control , THURSDAY, May ... have been encapsulated have been successfully transplanted into humans ... cells. , What,s more, scientists report, the transplanted pig ... to high blood sugar levels in the blood, improving ...
... releases (embargo: 6 May, 16:45 CEST) , J. Hicks, ... cells from very small samples , Researchers have developed a ... cells. The breakthrough allows them to study in fine detail ... Estrogen receptor status of HER2+ breast cancer correlates with response ...
... Brussels, 6 May 2010 -- An international team of ... some women with HER2 over-expressing breast cancer do not ... The research, presented at the IMPAKT Breast Cancer ... on future clinical trial design and treatment strategies in ...
Cached Medicine News:
... The Guidant Flextend ... transvenous pace/sense lead with ... The extendable/retractable helix design ... possibilities for permanent implantation ...
... profile endocardial permanent pacing leads with an ... size of only 4.8 F and a ... Physique lead is the smallest extendable/retractable bipolar ... straight and pre-formed J configurations, Physique leads ...
... The Vitatron Impulse II lead series ... designed to extend the longevity of ... efficient pacing. The high impedance of ... the small electrode surface, combined with ...
The CapSure Z Novus is an endocardial, tined, high-efficiency lead. High efficiency combined with steroid elution allows safe, low output programming....
Medicine Products: